Clinical Trial Update: Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the handling and safety of AVT06 prefilled syringe in subjects with chorioretinal vascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chorioretinal Vascular Disease

Drugs mentioned

• AVT06 (aflibercept)

Snippet

Sponsor: Alvotech Swiss AG | Conditions: Chorioretinal Vascular Disease | Phase 3 | Status: COMPLETED